Fundraising Fox

TYBR Health

YC W22 ↗

Houston, US · Founded 2020 · Delaware corporation · 3 employees · 4 known investors

tybrhealth.com ↗

Tybrhealth develops the B3 GEL™ System, a protective gel applied during tendon and ligament repair surgery to reduce post-operative scar formation and preserve tissue mobility. The product is marketed to surgeons seeking to improve functional outcomes for patients recovering from tendon repair procedures.

BiotechHealthtechMedical DevicesB2Bin /tybr-health/@ycombinatorycombinator.com ↗

Founders & leadership· Y Combinator alumni (W22)

TKTim Keane
Tim KeaneinFounder
ASAlex Smith
Alex SmithinFounder
TH
Toby HamiltonDirector
TD
Tom DuganDirector
JT
Jeffrey TyberDirector
TJ
Timothy J. Keane, Jr.Executive Officer, Director
AS
Aaron SmithDirector
LZ
Liz ZamboryDirector
SR
Stephen RamonExecutive Officer
CC
Cooper CollinsDirector
GB
Greg BankerDirector

Investors · 4

Asymmetry VenturesRichmond · $125K – $500Kvia Rob Ness · inferred
Y CombinatorSan Francisco · $500K
Mutual Capital Partnersreported · 2 sourcesCleveland · $1Mvia Liz Todia Zambory · board
Vensana Capitalreported · 2 sourcesMinneapolisvia Greg Banker · board

Reported raises · per SEC filings

Form D private placements
▶$14.4MraisedJul 2026 · 12 investors · Biotechnology
Rule 506(b)
TYBR raises $30M series A to scale surgical healing gel - InnovationMaphouston.innovationmap.com · Jul 2026TYBR Health Raises $30 Million Series A To Expand B3 GEL Systempulse2.com · Jul 2026
Officers, directors & promoters on the filing
  • Timothy J. Keane Jr.Executive Officer, Director
  • Alex SmithExecutive Officer, Director
  • Aaron SmithDirector
  • Jeffrey TyberDirector
  • Greg BankerDirector
  • Liz ZamboryDirector
  • Toby HamiltonDirector
Offering amount
$30M
Amount sold
$14.4M
First sale
Jul 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.1MraisedNov 2025 · 50 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Toby HamiltonDirector
  • Timothy J. KeaneExecutive Officer, Director
  • Alex SmithDirector
  • Tom DuganDirector
  • Jeffrey TyberDirector
Offering amount
$7.9M
Amount sold
$7.1M
First sale
Jan 2025
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$710KraisedDec 2020 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Timothy J. Keane, Jr.Executive Officer, Director, Promoter
  • Alex SmithExecutive Officer, Director, Promoter
  • Stephen RamonExecutive Officer
  • Cooper CollinsDirector
Offering amount
$1.3M
Amount sold
$710K
First sale
Nov 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news